China Resources Cement Q2 2025 Earnings Report

China Resources Cement EPS Results

• Actual EPS: $0.12
• Consensus EPS: N/A
• Beat/Miss: N/A
• One Year Ago EPS: N/A

China Resources Cement Revenue Results

• Actual Revenue: $771.37 million
• Expected Revenue: N/A
• Beat/Miss: N/A
• YoY Revenue Growth: N/A

China Resources Cement Announcement Details

• Quarter: Q2 2025
• Date: 8/15/2025
• Time: Before Market Opens
• Conference Call Date: N/A
• Conference Call Time: N/A

China Resources Cement (OTCMKTS:CARCY) Holdings Limited (OTCMKTS: CARCY) is a leading integrated producer of cement and building materials in the People’s Republic of China. As a subsidiary of the state-owned conglomerate China Resources Group, the company focuses on the manufacturing, distribution and sale of cement, clinker and related products. Headquartered in Hong Kong, China Resources Cement leverages its parent’s nationwide infrastructure to support construction and infrastructure development across mainland China.

The company’s core operations encompass the production of Portland cement, blended cement and specialty cements tailored for engineering and construction applications. Its vertically integrated business model includes raw material extraction, kiln firing, grinding facilities and logistics support. In addition to cement, China Resources Cement supplies aggregates and ready-mixed concrete, catering to both large‐scale infrastructure projects and residential property developments.

China Resources Cement maintains a broad geographic footprint, operating production facilities in southern, eastern and northern provinces of China. Its distribution network of terminals, depots and transportation assets ensures efficient delivery to customers in urban centers and rural markets alike. This extensive reach enables the company to participate in government-sponsored infrastructure initiatives as well as private sector developments.

Listed on the Hong Kong Stock Exchange, China Resources Cement also issues American depositary receipts that trade on the over-the-counter market in the United States under the symbol CARCY.